Subscribe to Newsletter

Maik Jornitz

President and CEO, G-CON Manufacturing

Jornitz has honed his bioprocessing expertise over the last 35 years in industry. As a subject matter expert in sterilizing grade filtration, he has published over 100 scientific articles and books on both facility design and bioprocess-related issues. Alongside his current role at G-CON, Jornitz has held several advisory positions. He was the former Chair of the PDA board of directors and science advisory board, and member of multiple PDA task forces. He now serves as a working member of ASTM E55, an advisory board member of the Biotechnology Industry Council, ICAV, Bondwell, DIANT Pharma and multiple scientific journals.

What has been the biggest breakthrough in biopharma in recent years?

I believe the biggest breakthrough is the shift to personalized medicinal treatments like cell and gene therapy. Not only do they show very promising results in fighting cancer, they are proving to be important for curing rare diseases.

There is still a long way to go before we can achieve optimal processes and facility designs for these products. The question as to whether the processes will end up at the point of care still remains. However, like with biologicals, time will show the best, most-affordable solutions for patients. What is certain is that the therapeutic promise is there, now we need to make the production and distribution happen and it is good to see how everybody works together to accomplish this feat.

Part of the Power List 2021

Find out more

Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products

Go to The Power List 2021

Part of the Power List 2020

The Power List 2020

Celebrating the great minds that bring us innovation in small molecules, biopharmaceuticals, and advanced medicine.

Go to The Power List 2020

Part of the Power List 2019

The Power List 2019

Breakthroughs at the bench, novel technologies and groundbreaking policies and regulation have helped the pharma industry grow from strength to strength. After months of collating reader nominations and judging overseen by a panel of industry experts, we proudly present The Medicine Maker 2019 Power List, featuring 100 of the industry’s pioneers across four categories: Industry Influencers, Business Captains, Masters of the Bench, and Champions of Change.

Go to The Power List 2019

Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018

Part of the Power List 2017

Our Top 100 into 4 categories

Go to The Power List 2017

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine